NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

Susan is Country President, Pfizer UK, leading the organisation to bring the power of innovation, data and technology together to transform healthcare and improve outcomes for patients. She is also Vice President of the ABPI.
Prior to this role, Susan led Pfizer UK’s Vaccines business unit during the COVID-19 pandemic, and previously led Pfizer’s UK Hospital business unit and Essential Health division.
Susan has been at Pfizer for two decades, with experience across multiple global markets including in the US, Asia and Europe. She moved to the UK in 2015 and lives in Surrey with her husband and son.
Susan is active within key industry fora, including as a member of the ABPI Board since April 2022, having previously been a co-opted ABPI Board and co-chair of the ABPI Vaccines Group since 2021. Susan also sits on the CBI President’s Committee and Health Council.
An error has occurred, please try again later.An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!